Endo Pharmaceuticals News
Most Popular Endo Pharmaceuticals Story
Endo Pharma CEO plots new round of deals
Over the past year Endo's new CEO, David Holveck (photo), has been steadily shifting the company's focus from pain management to new therapeutic arenas like oncology, doing $900 million worth of... Read more...
Latest Headlines
- December 3, 2009
- November 30, 2009
- August 26, 2009
- July 10, 2009
- June 11, 2009
- January 30, 2009
- January 6, 2009
- April 8, 2008
- February 20, 2008
- October 1, 2007
- December 5, 2006
- October 12, 2006
- September 5, 2006
- July 5, 2006
- June 22, 2006
- August 21, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
